← Back to Search

Dietary Supplement

Testosterone for Aging (GRAMS Trial)

Phase 1
Waitlist Available
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post-discharge
Awards & highlights

GRAMS Trial Summary

This trial will study how well two different interventions help older adults recover from a hospital stay.

GRAMS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post-discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Performance
Secondary outcome measures
30 day re-admission
Handgrip Strength
Physical Activity Level

GRAMS Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: TestosteroneExperimental Treatment2 Interventions
Placebo Supplement Testosterone Injection
Group II: Protein Supplement + TestosteroneExperimental Treatment2 Interventions
Protein Supplement Testosterone Injection
Group III: Protein SupplementExperimental Treatment2 Interventions
Protein Supplement Placebo Injection
Group IV: PlaceboPlacebo Group2 Interventions
Placebo Supplement Placebo Injection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Testosterone
2009
Completed Phase 4
~2020
Protein Supplement
2009
Completed Phase 3
~5380

Find a Location

Who is running the clinical trial?

The University of Texas Medical Branch, GalvestonLead Sponsor
241 Previous Clinical Trials
56,518 Total Patients Enrolled
10 Trials studying Aging
798 Patients Enrolled for Aging
Elena Volpi, MD, PhDStudy ChairUTMB
6 Previous Clinical Trials
2,732 Total Patients Enrolled
3 Trials studying Aging
368 Patients Enrolled for Aging

Media Library

Protein Supplement (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT02990533 — Phase 1
Aging Research Study Groups: Placebo, Testosterone, Protein Supplement, Protein Supplement + Testosterone
Aging Clinical Trial 2023: Protein Supplement Highlights & Side Effects. Trial Name: NCT02990533 — Phase 1
Protein Supplement (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02990533 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current quota of participants accepted into this investigation?

"Currently, this clinical trial is not taking on any new patients. It was first posted on September 1st 2016 and the most recent changes were made to it on April 13th 2022. However, if you are exploring other studies there are 245 trials that have aging as their focus and 6 for Testosterone currently accepting participants."

Answered by AI

To what extent has Testosterone been evaluated in other clinical research studies?

"Currently, there are 6 ongoing clinical trials for Testosterone with none of them currently in the third phase. The majority of these experiments take place within Galveston, Texas yet 7 different locations in total are evaluating Testosterone's efficacy."

Answered by AI

Has Testosterone been officially endorsed by the Food and Drug Administration?

"The safety of testosterone is rated as low, a score of 1. This can be attributed to the fact that it's still in Phase 1, thus there are only preliminary results demonstrating its efficacy and limited data supporting safety."

Answered by AI

Is this medical experiment currently recruiting participants?

"Per clinicaltrials.gov, this research study is no longer accepting participants as of April 13th 2022; it was initially posted on September 1st 2016. Notwithstanding, there are still 251 other trials requiring volunteers presently."

Answered by AI
~9 spots leftby Apr 2025